PRA Health Sciences (PRAH) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook
Get Alerts PRAH Hot Sheet
Join SI Premium – FREE
PRA Health Sciences (NASDAQ: PRAH) reported Q1 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $372.3 million versus the consensus estimate of $372.21 million.
GUIDANCE:
PRA Health Sciences sees FY2016 EPS of $2.41-$2.48, versus prior guidance of $2.32-$2.42 and the consensus of $2.38.
For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Community West Bancshares (CWBC) Tops Q1 EPS by 7c
- Marten Transport (MRTN) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!